PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 97018602 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 119 |
MARK SECTION | |
MARK | ABRYSVO (see, http://uspto.report/TM/97018602/mark.png) |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | ABRYSVO |
OWNER SECTION (current) | |
NAME | Pfizer Inc. |
MAILING ADDRESS | 235 East 42nd Street |
CITY | New York |
STATE | New York |
ZIP/POSTAL CODE | 10017 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
PHONE | 212-733-0086 |
XXXX | |
OWNER SECTION (proposed) | |
NAME | Pfizer Inc. |
MAILING ADDRESS | 235 East 42nd Street |
CITY | New York |
STATE | New York |
ZIP/POSTAL CODE | 10017 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
PHONE | 212-733-0086 |
XXXX | |
CORRESPONDENCE INFORMATION (current) | |
NAME | RICHARD A. FRIEDMAN |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | deadlinesipnyo@pfizer.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | docketingipnyo@pfizer.com |
CORRESPONDENCE INFORMATION (proposed) | |
NAME | Richard A. Friedman |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | deadlinesipnyo@pfizer.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | docketingipnyo@pfizer.com |
GOODS AND/OR SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
CURRENT IDENTIFICATION | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use |
GOODS OR SERVICES | KEEP ALL LISTED |
EXTENSION SECTION | |
EXTENSION NUMBER | 1 |
ALLOWANCE MAIL DATE | 08/30/2022 |
STATEMENT OF USE | NO |
PAYMENT SECTION | |
NUMBER OF CLASSES | 1 |
SUBTOTAL AMOUNT [EXTENSION FEE] | 125 |
TOTAL AMOUNT | 125 |
SIGNATURE SECTION | |
SIGNATURE | /RAF/ |
SIGNATORY'S NAME | Richard A. Friedman |
SIGNATORY'S POSITION | Assistant General Counsel |
DATE SIGNED | 01/05/2023 |
SIGNATORY'S PHONE NUMBER | 212-733-0086 |
SIGNATURE METHOD | Sent to third party for signature |
FILING INFORMATION | |
SUBMIT DATE | Thu Jan 05 16:04:23 ET 2023 |
TEAS STAMP | USPTO/ESU-XXX.XXX.XX.X-20 230105160423939363-970186 02-850f9914ad7dd846c888a8 96af53e53761edb968bef8cec 410be97479bf8251f-DA-0423 3223-20230105144328061631 |
PTO- 1581 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |